Your session is about to expire
← Back to Search
AC682 for Advanced Breast Cancer
Study Summary
This trial is testing a new drug, AC682, for people with a certain type of breast cancer. The goals are to see how safe it is, what side effects it has, how it works in the body, and how well it works against the cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many venues are hosting this clinical experiment?
"The 6 clinical sites administering this study comprise of Sarah Cannon Research Institute at HealthONE in Denver, Site 04 in Orlando and Site 02 in Sarasota as well as additional medical centres."
How many participants are currently engaging in this research project?
"The trial sponsor, Accutar Biotechnology Inc., necessitates the recruitment of 30 qualifying patients to begin the study. The research will be conducted from locations such as Sarah Cannon Research Institute at HealthONE in Denver and Site 04 located in Orlando, Florida."
Are participants currently being accepted for this experiment?
"Affirmative. As indicated on clinicaltrials.gov, this clinical trial - which was initially posted on November 12th 2021- is actively looking for volunteers. This study seeks 30 participants across 6 sites."
Has the Food and Drug Administration accepted AC682 as a safe medical solution?
"AC682's safety profile is estimated to be a 1, as it has only experienced initial clinical testing and lacks sufficient evidence of its efficacy."
Share this study with friends
Copy Link
Messenger